Anticipated Shortage

LORAZEPAM SUBLINGUAL

AA PHARMA INC

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of LORAZEPAM SUBLINGUAL in Canada?

A shortage of LORAZEPAM SUBLINGUAL 0.5MG is expected: the manufacturer reported it to Health Canada as an anticipated shortage (last updated September 30, 2026), but it has not started yet.

Why is LORAZEPAM SUBLINGUAL not available?

The reason the manufacturer reported: Disruption of the manufacture of the drug.

When will LORAZEPAM SUBLINGUAL be available again?

No estimated resolution date has been reported yet. Follow this page to get an email as soon as the status changes.

Can I still get this?Check with your pharmacist — only products with a different form or route found

StatusAnticipated Shortage

Same-ingredient products on file3 products · 0 same form & route

Affected strength0.5MG

Report last updated2026-09-30

Checked by MedShort2026-11-12

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Other Products

PRO-LORAZEPAM

PRO DOC LIMITEE

1MG · DIN 00655651

Different strengthSame dosage formDifferent routeNo current shortage

Compare these two →

LORAZEPAM INJECTION USP

SANDOZ CANADA INCORPORATED

4MG · DIN 02243278

Different strengthDifferent dosage formDifferent routeNo current shortage

Compare these two →

LORAZEPAM INJECTION, USP

FRESENIUS KABI CANADA LTD

4MG · DIN 02550962

Different strengthDifferent dosage formDifferent routeNo current shortage

Compare these two →

What this means

Does this mean my pharmacy is already out of stock?

No — this shortage hasn't started yet. It's an early warning that supply may become tight, based on information from the manufacturer.

What should I do?

No action is needed yet. It's worth asking your pharmacist at your next refill whether they expect any disruption for this product.

Have you checked a pharmacy recently?

No community reports yet — be the first to share what you found.

Community reports are not verified by a pharmacy and may reflect a small sample size. This is not a guarantee of current stock.

DIN

02410745

Strength

0.5MG

Dosage Form

TABLET

Route

SUBLINGUAL

Active Ingredient

LORAZEPAM

Tier

Unrated

Last Updated

2026-09-30

Reason for Shortage

Disruption of the manufacture of the drug.

Source

View original report on healthproductshortages.ca ↗

Other Products from AA PHARMA INC

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

10MG · DIN 02420333

DIN 00784400

DIN 02248764

DIN 02248763

200MG · DIN 02458756

100MG · DIN 02248035